Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 12
Submit an article Journal homepage
451
Views
2
CrossRef citations to date
0
Altmetric
Oncology

First-line treatment disruption among post-menopausal women with HR+/HER2– metastatic breast cancer: a retrospective US claims study

Derek H. TangNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Correspondence[email protected]
,
Nanxin LiAnalysis Group, Inc., Boston, MA, USA;
,
Ella X. DuAnalysis Group, Inc., Los Angeles, CA, USA;
,
Miranda PeeplesAnalysis Group, Inc., Boston, MA, USA;
,
Lihao ChuAnalysis Group, Inc., Los Angeles, CA, USA;
,
Jipan XieAnalysis Group, Inc., Los Angeles, CA, USA;
&
Victoria BarghoutVEB HealthCare LLC, Morristown, NJ, USA
 show all
Pages 2137-2143 | Received 25 Apr 2017, Accepted 06 Oct 2017, Published online: 27 Oct 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nicole Princic, Ayal Aizer, Derek H. Tang, David M. Smith, William Johnson & Aditya Bardia. (2019) Predictors of systemic therapy sequences following a CDK 4/6 inhibitor-based regimen in post-menopausal women with hormone receptor positive, HEGFR-2 negative metastatic breast cancer. Current Medical Research and Opinion 35:1, pages 73-80.
Read now

Articles from other publishers (1)

Qiuyue Liu, Juan Qiu, Qianrun Lu, Yujin Ma, Shu Fang, Bing Bu & Lihua Song. (2022) Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study. Frontiers in Oncology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.